Subsidiary of Pinnacle Food Group Limited Enters into Biotechnology Research Collaboration Agreement

Pinnacle Food Group (Nasdaq: PFAI) announced on Jan 28, 2026 that its subsidiary Pinnacle Food AgTech HK entered a research and technology collaboration with Bioboost Synbio Consulting.

Rhea-AI Summary

Pinnacle Food Group (Nasdaq: PFAI) announced on Jan 28, 2026 that its subsidiary Pinnacle Food AgTech HK entered a research and technology collaboration with Bioboost Synbio Consulting. The agreement focuses on biotechnology and precision fermentation research, including recombinant human lactoferrin (rhLF) applications.

The collaboration covers technical consulting, ecosystem scouting, and evaluation of research directions to advance the company’s smart agriculture and advanced fermentation capabilities.

Argus Jan 28 session

+6.79% close to close Open Argus

Details

News Market Reaction – PFAI

On Jan 28, the day this news came out, PFAI closed 6.79% above the previous close.

Data tracked by StockTitan Argus for the Jan 28 session.

Key Figures

Announcement date: Jan. 28, 2026

Announcement date

Jan. 28, 2026

Collaboration agreement press release date

Historical Context

2 past events · Latest: Nov 24

2 events

1. Nov 24

   Bioengineering initiative

   24h Move

   +0.0%

   Announced new bioengineering lab to expand smart agriculture platform with consulting support.

2. Aug 12

   Industry forum sponsorship

   24h Move

   -4.5%

   Sponsored smart farming forum in Vancouver to promote standards and collaboration in sector.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

precision fermentation, recombinant human lactoferrin (rhLF), biotechnology

3 terms

precision fermentation technical

"collaborate on biotechnology and precision fermentation research applications, including research"

Precision fermentation uses edited microbes (like yeast or bacteria) as tiny, programmable factories to produce a single, specific ingredient—such as a protein, enzyme or flavor—rather than making whole foods. Think of it like coding a vending machine to dispense one exact product on demand. For investors, it matters because it can cut production costs, speed up scale-up, reduce reliance on traditional agriculture or chemical synthesis, and create new, high-margin products that can reshape markets and regulatory pathways.

recombinant human lactoferrin (rhLF) medical

"including research activities related to recombinant human lactoferrin (rhLF), a naturally"

Recombinant human lactoferrin (rhlf) is a lab-made version of a natural protein produced in the body that helps bind iron and supports immune defenses; think of it as a manufactured copy of a body's own protective molecule. It matters to investors because rhlf is being developed as a therapeutic, supplement or ingredient for infant formula and wound care, so clinical results, regulatory approvals, manufacturing capacity and supply deals can directly affect a company’s revenue and valuation.

biotechnology technical

"collaborate on biotechnology and precision fermentation research applications, including"

Biotechnology is the use of living cells, molecules, or biological processes as tools to create products, treatments, or industrial processes—think of it as using nature’s toolbox to solve problems like disease, food production, or pollution. For investors it matters because biotech ventures can deliver big breakthroughs and rapid growth but also face long development timelines, strict regulatory checks, and binary outcomes (success or failure), so potential reward comes with significant risk and uncertainty.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, BC, Jan. 28, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven smart farming and bio-engineering company, providing integrated farming-as-a-service solutions and developing biology-enabled platforms to support efficient and sustainable food systems, today announced that its wholly owned subsidiary, Pinnacle Food AgTech HK Limited, has entered into a research and technology collaboration agreement with Bioboost Synbio Consulting Inc., a biotechnology consulting company based in Vancouver, Canada.

Under the agreement, the parties will collaborate on biotechnology and precision fermentation research applications, including research activities related to recombinant human lactoferrin (rhLF), a naturally occurring protein found in human milk that is recognized for its potential applications in health, nutrition, and functional food development. The collaboration will also include technical consulting services, ecosystem scouting, and the evaluation of research directions and technical feasibility, including but not limited to areas related to agricultural technology, food technology and biotechnology.

The Company believes that this collaboration is consistent with its ongoing research and technology development efforts in smart agriculture and advanced fermentation, and is intended to advance technical understanding and research capabilities in these areas.

Commenting on the collaboration, Jiulong You, Chief Executive Officer of Pinnacle Food Group Limited, stated: "This collaboration represents an important step in strengthening our research capabilities in precision fermentation and advanced biotechnology. By working with experienced research partners, we aim to explore the technical potential of innovative bioproducts and deepen our understanding of how emerging technologies can support the future of agriculture, food, and nutrition."

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. federal securities laws, including statements regarding the Company's expectations, research objectives, and the anticipated scope and implications of the collaboration. These forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. The Company undertakes no obligation to update any forward-looking statements, except as required by applicable law.

Investor Relations Contact

Jiulong You
Email: ir@pinnaclefoodinc.com
Phone: +1 (604) 727-7204

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/subsidiary-of-pinnacle-food-group-limited-enters-into-biotechnology-research-collaboration-agreement-302671943.html

SOURCE Pinnacle Food Group Limited

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pinnacle Food Group (PFAI) announce on January 28, 2026 about a research collaboration?

Pinnacle Food Group announced a research and technology collaboration with Bioboost Synbio Consulting. According to the company, the agreement covers precision fermentation research, technical consulting, ecosystem scouting, and evaluation of recombinant human lactoferrin (rhLF) research directions.

What research areas will PFAI and Bioboost Synbio focus on under the collaboration?

They will focus on biotechnology and precision fermentation research, including recombinant human lactoferrin (rhLF). According to the company, work also includes agricultural technology, food technology, technical consulting and ecosystem scouting activities.

How does the PFAI collaboration aim to affect Pinnacle Food Group’s R&D capabilities?

The collaboration aims to strengthen Pinnacle Food Group’s research capabilities in precision fermentation and advanced biotechnology. According to the company, partnering with experienced research advisors is intended to deepen technical understanding and advance research capabilities.

Will the PFAI collaboration produce commercial products or immediate revenue for shareholders?

The announcement describes research and evaluation work, not immediate commercialization or revenue. According to the company, the agreement is intended to advance technical understanding and research capabilities rather than announce product launches or sales.

Which specific protein is mentioned in the PFAI research collaboration and why is it significant?

The collaboration mentions recombinant human lactoferrin (rhLF), a protein with potential health and nutrition uses. According to the company, rhLF is recognized for possible applications in health, nutrition, and functional food development.